Dr. Reddy’s launches generic Vimovo
Dr. Reddy’s announced it is launching the first-to-market naproxen and esomeprazole magnesium delayed-release tablets.
The product is the generic of Horizon’s Vimovo.
“This launch is a testament to our core strengths in areas of research and development and intellectual property,” said Marc Kikuchi, Dr. Reddy’s CEO, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo tablets and to provide an affordable treatment alternative for patients.”
Vimovo has a market value of approximately $414 million for the 12 months ended December 2019, according to IQVIA.
Dr. Reddy’s product is available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.